Lithium Carbonate Tablet, Extended Release
Product Images NDC 70518-3681

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 70518-3681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of Lithium Carbonate extended-release tablets with a dosage of 300 mg. There are 30 tablets in a quantity. The medication is available by prescription only, and the NDC # is 70518-3681-00. The manufacturing company is WestWard Pharma located in Eatontown, NJ 07724. The expiration date and lot # are not available. The package should be kept out of reach of children and directions for use should be referred to the package insert. The medication should be stored at a temperature of 20-25°C (88-77°F), with excursions permitted to be between 15-30°C (59-86°F) [See USP]. The packaging has been done by RemedyRepack Inc. located in Indiana,PA 15701.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.